Shibo Jiang

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 132

Top Venues

Signal transduction and targeted therapy

Journal of medical virology

Viruses

Cell discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Yulu Wang, Yifang Sun, Zhaoling Shen, Cong Wang, Jun Qian, Qiyu Mao, Yajie Wang, Wenping Song, Yu Kong, Changyou Zhan, Zhenguo Chen, Dimiter S Dimitrov, Zhenlin Yang, Shibo Jiang, Fan Wu, Lu Lu, Tianlei Ying, Lei Sun, Yanling Wu
Fully human single-domain antibody targeting a highly conserved cryptic epitope on the Nipah virus G protein. Nature communications 15 (1) (2024)
Lijue Wang, Fanke Jiao, Hanxiao Jiang, Yitao Yang, Ziqi Huang, Qian Wang, Wei Xu, Yun Zhu, Shuai Xia, Shibo Jiang, Lu Lu
Fusogenicity of SARS-CoV-2 BA.2.86 subvariant and its sensitivity to the prokaryotic recombinant EK1 peptide. Cell discovery 10 (1) (2024)
Suiyi Tan, Wenjuan Li, Chan Yang, Qingping Zhan, Kunyu Lu, Jun Liu, Yong-Mei Jin, Jin-Song Bai, Lin Wang, Jinqing Li, Zhaofeng Li, Fei Yu, Yu-Ye Li, Yue-Xun Duan, Lu Lu, Tong Zhang, Jiaqi Wei, Lin Li, Yong-Tang Zheng, Shibo Jiang, Shu-Wen Liu
gp120-derived amyloidogenic peptides form amyloid fibrils that increase HIV-1 infectivity. Cellular & molecular immunology 21 (5) (2024)
Lijue Wang, Fanke Jiao, Hanxiao Jiang, Yitao Yang, Ziqi Huang, Qian Wang, Wei Xu, Yun Zhu, Shuai Xia, Shibo Jiang, Lu Lu
Fusogenicity of SARS-CoV-2 BA.2.86 subvariant and its sensitivity to the prokaryotic recombinant EK1 peptide. Cell discovery 10 (1) (2024)
Chao Wang, Wenpeng Zhang, Ling Xu, Jiahuang Tu, Shan Su, Qing Li, Tao Zhang, Longbo Zheng, Huan Wang, Xiaomei Zhuang, Xuan Tang, Yu Yuan, Guangpeng Meng, Lu Lu, Junhai Xiao, Qian Wang, Shibo Jiang
Discovery of a Double-Stapled Short Peptide as a Long-Acting HIV-1 Inactivator with Potential for Oral Bioavailability. Journal of medicinal chemistry 67 (12) (2024)
Chao Wang, Wenpeng Zhang, Ling Xu, Jiahuang Tu, Shan Su, Qing Li, Tao Zhang, Longbo Zheng, Huan Wang, Xiaomei Zhuang, Xuan Tang, Yu Yuan, Guangpeng Meng, Lu Lu, Junhai Xiao, Qian Wang, Shibo Jiang
Discovery of a Double-Stapled Short Peptide as a Long-Acting HIV-1 Inactivator with Potential for Oral Bioavailability. Journal of medicinal chemistry (2024)
Xiong Xie, Qiaoshuai Lan, Jinyi Zhao, Sulin Zhang, Lu Liu, Yumin Zhang, Wei Xu, Maolin Shao, Jingjing Peng, Shuai Xia, Yan Zhu, Keke Zhang, Xianglei Zhang, Ruxue Zhang, Jian Li, Wenhao Dai, Zhen Ge, Shulei Hu, Changyue Yu, Jiang Wang, Dakota Ma, Mingyue Zheng, Haitao Yang, Geng-Fu Xiao, Zihe Rao, Lu Lu, Lei-Ke Zhang, Fang Bai, Yao Zhao, Shibo Jiang, Hong Liu
Structure-based design of pan-coronavirus inhibitors targeting host cathepsin L and calpain-1. Signal transduction and targeted therapy 9 (1) (2024)
Wenjie Qu, Chen Hua, Yaping Wang, Yan Wang, Lu Zhang, Zhiheng Wang, Wenqian Shi, Fang Chen, Zhiyong Wu, Qian Wang, Lu Lu, Shibo Jiang, Long Sui, Yanyun Li
Lineage Replacement and Genetic Changes of Four HR-HPV Types during the Period of Vaccine Coverage: A Six-Year Retrospective Study in Eastern China. Vaccines 12 (4) (2024)
Suiyi Tan, Wenjuan Li, Chan Yang, Qingping Zhan, Kunyu Lu, Jun Liu, Yong-Mei Jin, Jin-Song Bai, Lin Wang, Jinqing Li, Zhaofeng Li, Fei Yu, Yu-Ye Li, Yue-Xun Duan, Lu Lu, Tong Zhang, Jiaqi Wei, Lin Li, Yong-Tang Zheng, Shibo Jiang, Shu-Wen Liu
gp120-derived amyloidogenic peptides form amyloid fibrils that increase HIV-1 infectivity. Cellular & molecular immunology 21 (5) (2024)
Lijue Wang, Fanke Jiao, Hanxiao Jiang, Yitao Yang, Ziqi Huang, Qian Wang, Wei Xu, Yun Zhu, Shuai Xia, Shibo Jiang, Lu Lu
Fusogenicity of SARS-CoV-2 BA.2.86 subvariant and its sensitivity to the prokaryotic recombinant EK1 peptide. Cell discovery 10 (1) (2024)
Najing Cao, Yanxing Cai, Xin Huang, Hanxiao Jiang, Ziqi Huang, Lixiao Xing, Lu Lu, Shibo Jiang, Wei Xu
Inhibition of influenza A virus and SARS-CoV-2 infection or co-infection by griffithsin and griffithsin-based bivalent entry inhibitor. mBio (2024)
Najing Cao, Yanxing Cai, Xin Huang, Hanxiao Jiang, Ziqi Huang, Lixiao Xing, Lu Lu, Shibo Jiang, Wei Xu
Inhibition of influenza A virus and SARS-CoV-2 infection or co-infection by griffithsin and griffithsin-based bivalent entry inhibitor. mBio 15 (5) (2024)
Xiong Xie, Qiaoshuai Lan, Jinyi Zhao, Sulin Zhang, Lu Liu, Yumin Zhang, Wei Xu, Maolin Shao, Jingjing Peng, Shuai Xia, Yan Zhu, Keke Zhang, Xianglei Zhang, Ruxue Zhang, Jian Li, Wenhao Dai, Zhen Ge, Shulei Hu, Changyue Yu, Jiang Wang, Dakota Ma, Mingyue Zheng, Haitao Yang, Geng-Fu Xiao, Zihe Rao, Lu Lu, Lei-Ke Zhang, Fang Bai, Yao Zhao, Shibo Jiang, Hong Liu
Structure-based design of pan-coronavirus inhibitors targeting host cathepsin L and calpain-1. Signal transduction and targeted therapy 9 (1) (2024)
Suiyi Tan, Wenjuan Li, Chan Yang, Qingping Zhan, Kunyu Lu, Jun Liu, Yong-Mei Jin, Jin-Song Bai, Lin Wang, Jinqing Li, Zhaofeng Li, Fei Yu, Yu-Ye Li, Yue-Xun Duan, Lu Lu, Tong Zhang, Jiaqi Wei, Lin Li, Yong-Tang Zheng, Shibo Jiang, Shu-Wen Liu
gp120-derived amyloidogenic peptides form amyloid fibrils that increase HIV-1 infectivity. Cellular & molecular immunology (2024)
Naru Zhang, Zihui Ye, Cun Li, Jie Zhou, Wei Xue, Luying Xiang, Yuewen Chen, Shuchang Chen, Rouhan Ye, Jingyin Dong, Jie Zhou, Shibo Jiang, Haijun Han
A subunit-based influenza/SARS-CoV-2 Omicron combined vaccine induced potent protective immunity in BALB/c mice. Journal of medical virology 96 (3) (2024)
Suiyi Tan, Wenjuan Li, Chan Yang, Qingping Zhan, Kunyu Lu, Jun Liu, Yong-Mei Jin, Jin-Song Bai, Lin Wang, Jinqing Li, Zhaofeng Li, Fei Yu, Yu-Ye Li, Yue-Xun Duan, Lu Lu, Tong Zhang, Jiaqi Wei, Lin Li, Yong-Tang Zheng, Shibo Jiang, Shu-Wen Liu
gp120-derived amyloidogenic peptides form amyloid fibrils that increase HIV-1 infectivity. Cellular & molecular immunology 21 (5) (2024)
Xiong Xie, Qiaoshuai Lan, Jinyi Zhao, Sulin Zhang, Lu Liu, Yumin Zhang, Wei Xu, Maolin Shao, Jingjing Peng, Shuai Xia, Yan Zhu, Keke Zhang, Xianglei Zhang, Ruxue Zhang, Jian Li, Wenhao Dai, Zhen Ge, Shulei Hu, Changyue Yu, Jiang Wang, Dakota Ma, Mingyue Zheng, Haitao Yang, Geng-Fu Xiao, Zihe Rao, Lu Lu, Lei-Ke Zhang, Fang Bai, Yao Zhao, Shibo Jiang, Hong Liu
Structure-based design of pan-coronavirus inhibitors targeting host cathepsin L and calpain-1. Signal transduction and targeted therapy 9 (1) (2024)
Yulu Wang, Yifang Sun, Zhaoling Shen, Cong Wang, Jun Qian, Qiyu Mao, Yajie Wang, Wenping Song, Yu Kong, Changyou Zhan, Zhenguo Chen, Dimiter S Dimitrov, Zhenlin Yang, Shibo Jiang, Fan Wu, Lu Lu, Tianlei Ying, Lei Sun, Yanling Wu
Fully human single-domain antibody targeting a highly conserved cryptic epitope on the Nipah virus G protein. Nature communications 15 (1) (2024)
Najing Cao, Yanxing Cai, Xin Huang, Hanxiao Jiang, Ziqi Huang, Lixiao Xing, Lu Lu, Shibo Jiang, Wei Xu
Inhibition of influenza A virus and SARS-CoV-2 infection or co-infection by griffithsin and griffithsin-based bivalent entry inhibitor. mBio 15 (5) (2024)
Yulu Wang, Yifang Sun, Zhaoling Shen, Cong Wang, Jun Qian, Qiyu Mao, Yajie Wang, Wenping Song, Yu Kong, Changyou Zhan, Zhenguo Chen, Dimiter S Dimitrov, Zhenlin Yang, Shibo Jiang, Fan Wu, Lu Lu, Tianlei Ying, Lei Sun, Yanling Wu
Fully human single-domain antibody targeting a highly conserved cryptic epitope on the Nipah virus G protein. Nature communications 15 (1) (2024)
Chao Wang, Wenpeng Zhang, Ling Xu, Jiahuang Tu, Shan Su, Qing Li, Tao Zhang, Longbo Zheng, Huan Wang, Xiaomei Zhuang, Xuan Tang, Yu Yuan, Guangpeng Meng, Lu Lu, Junhai Xiao, Qian Wang, Shibo Jiang
Discovery of a Double-Stapled Short Peptide as a Long-Acting HIV-1 Inactivator with Potential for Oral Bioavailability. Journal of medicinal chemistry 67 (12) (2024)
Wenjie Qu, Chen Hua, Yaping Wang, Yan Wang, Lu Zhang, Zhiheng Wang, Wenqian Shi, Fang Chen, Zhiyong Wu, Qian Wang, Lu Lu, Shibo Jiang, Long Sui, Yanyun Li
Lineage Replacement and Genetic Changes of Four HR-HPV Types during the Period of Vaccine Coverage: A Six-Year Retrospective Study in Eastern China. Vaccines 12 (4) (2024)
Xiong Xie, Qiaoshuai Lan, Jinyi Zhao, Sulin Zhang, Lu Liu, Yumin Zhang, Wei Xu, Maolin Shao, Jingjing Peng, Shuai Xia, Yan Zhu, Keke Zhang, Xianglei Zhang, Ruxue Zhang, Jian Li, Wenhao Dai, Zhen Ge, Shulei Hu, Changyue Yu, Jiang Wang, Dakota Ma, Mingyue Zheng, Haitao Yang, Geng-Fu Xiao, Zihe Rao, Lu Lu, Lei-Ke Zhang, Fang Bai, Yao Zhao, Shibo Jiang, Hong Liu
Structure-based design of pan-coronavirus inhibitors targeting host cathepsin L and calpain-1. Signal transduction and targeted therapy 9 (1) (2024)
Najing Cao, Yanxing Cai, Xin Huang, Hanxiao Jiang, Ziqi Huang, Lixiao Xing, Lu Lu, Shibo Jiang, Wei Xu
Inhibition of influenza A virus and SARS-CoV-2 infection or co-infection by griffithsin and griffithsin-based bivalent entry inhibitor. mBio 15 (5) (2024)
Suiyi Tan, Wenjuan Li, Chan Yang, Qingping Zhan, Kunyu Lu, Jun Liu, Yong-Mei Jin, Jin-Song Bai, Lin Wang, Jinqing Li, Zhaofeng Li, Fei Yu, Yu-Ye Li, Yue-Xun Duan, Lu Lu, Tong Zhang, Jiaqi Wei, Lin Li, Yong-Tang Zheng, Shibo Jiang, Shu-Wen Liu
gp120-derived amyloidogenic peptides form amyloid fibrils that increase HIV-1 infectivity. Cellular & molecular immunology (2024)
Najing Cao, Yanxing Cai, Xin Huang, Hanxiao Jiang, Ziqi Huang, Lixiao Xing, Lu Lu, Shibo Jiang, Wei Xu
Inhibition of influenza A virus and SARS-CoV-2 infection or co-infection by griffithsin and griffithsin-based bivalent entry inhibitor. mBio (2024)
Shibo Li, Jianbo Wu, Weiyu Jiang, Haiyan He, Yunjiao Zhou, Wei Wu, Yidan Gao, Minxiang Xie, Anqi Xia, Jiaying He, Qianqian Zhang, Yuru Han, Nan Wang, Guangqi Zhu, Qiujing Wang, Zheen Zhang, Christian T Mayer, Kang Wang, Xiangxi Wang, Junqing Wang, Zhenguo Chen, Shibo Jiang, Lei Sun, Rong Xia, Qiao Wang
Characterization of cross-reactive monoclonal antibodies against SARS-CoV-1 and SARS-CoV-2: Implication for rational design and development of pan-sarbecovirus vaccines and neutralizing antibodies. Journal of medical virology 95 (2) (2023)
Shuai Xia, Fanke Jiao, Lijue Wang, Xueying Yu, Tianyu Lu, Yan Fu, Ziqi Huang, Xicheng Li, Jinghe Huang, Qian Wang, Qiuhong Man, Lize Xiong, Shibo Jiang, Lu Lu
SARS-CoV-2 Omicron XBB subvariants exhibit enhanced fusogenicity and substantial immune evasion in elderly population, but high sensitivity to pan-coronavirus fusion inhibitors. Journal of medical virology (2023)
Xiaojie Su, Ziqi Huang, Wei Xu, Qian Wang, Lixiao Xing, Lu Lu, Shibo Jiang, Shuai Xia
IgG Fc-Binding Peptide-Conjugated Pan-CoV Fusion Inhibitor Exhibits Extended In Vivo Half-Life and Synergistic Antiviral Effect When Combined with Neutralizing Antibodies. Biomolecules 13 (9) (2023)
Mengwen Huang, Xingchao Pan, Xinling Wang, Qingfei Ren, Bei Tong, Xianchi Dong, GaoXiang Ge, Lu Lu, Shibo Jiang, Jian-Feng Chen
Lymphocyte integrins mediate entry and dysregulation of T cells by SARS-CoV-2. Signal transduction and targeted therapy 8 (1) (2023)
Chao Wang, Qing Li, Lujia Sun, Xinling Wang, Huan Wang, Wenpeng Zhang, Jiahui Li, Yang Liu, Lu Lu, Shibo Jiang
An Artificial Peptide-Based Bifunctional HIV-1 Entry Inhibitor That Interferes with Viral Glycoprotein-41 Six-Helix Bundle Formation and Antagonizes CCR5 on the Host Cell Membrane. Viruses 15 (5) (2023)
Zijie Lin, Lujia Sun, Liliang Li, Shibo Jiang
Nasal mucosa is much more susceptible than oral mucosa to infection of SARS-CoV-2 Omicron subvariants: Wearing nasal masks where facial masks cannot be used. Journal of medical virology 95 (2) (2023)
Shuai Xia, Lijue Wang, Fanke Jiao, Xueying Yu, Wei Xu, Ziqi Huang, Xicheng Li, Qian Wang, Yun Zhu, Qiuhong Man, Shibo Jiang, Lu Lu
SARS-CoV-2 Omicron subvariants exhibit distinct fusogenicity, but similar sensitivity, to pan-CoV fusion inhibitors. Emerging microbes & infections (2023)
Mengwen Huang, Xingchao Pan, Xinling Wang, Qingfei Ren, Bei Tong, Xianchi Dong, GaoXiang Ge, Lu Lu, Shibo Jiang, Jian-Feng Chen
Lymphocyte integrins mediate entry and dysregulation of T cells by SARS-CoV-2. Signal transduction and targeted therapy 8 (1) (2023)
Qiao Wang, Lujia Sun, Shibo Jiang
Potential recombination between SARS-CoV-2 and MERS-CoV: calls for the development of Pan-CoV vaccines. Signal transduction and targeted therapy 8 (1) (2023)
Xinling Wang, Lujia Sun, Zezhong Liu, Lixiao Xing, Yun Zhu, Wei Xu, Shuai Xia, Lu Lu, Shibo Jiang
An engineered recombinant protein containing three structural domains in SARS-CoV-2 S2 protein has potential to act as a pan-human coronavirus entry inhibitor or vaccine antigen. Emerging microbes & infections (2023)
Zijie Lin, Lujia Sun, Liliang Li, Shibo Jiang
Nasal mucosa is much more susceptible than oral mucosa to infection of SARS-CoV-2 Omicron subvariants: Wearing nasal masks where facial masks cannot be used. Journal of medical virology 95 (2) (2023)
Zijie Lin, Lujia Sun, Liliang Li, Shibo Jiang
Nasal mucosa is much more susceptible than oral mucosa to infection of SARS-CoV-2 Omicron subvariants: wearing nasal masks where facial masks cannot be used. Journal of medical virology (2023)
Songyi Xue, Wei Xu, Lei Wang, Ling Xu, Laurent Calcul, Peng Teng, Lu Lu, Shibo Jiang, Jianfeng Cai
Rational Design of Sulfonyl-γ-AApeptides as Highly Potent HIV-1 Fusion Inhibitors with Broad-Spectrum Activity. Journal of medicinal chemistry (2023)
Fanlin Li, Wei Xu, Xiaoqing Zhang, Wanting Wang, Shan Su, Ping Han, Haiyong Wang, Yanqin Xu, Min Li, Lilv Fan, Huihui Zhang, Qiang Dai, Hao Lin, Xinyue Qi, Jie Liang, Xin Wang, Shibo Jiang, You-Hua Xie, Lu Lu, Xuanming Yang
A spike-targeting bispecific T cell engager strategy provides dual layer protection against SARS-CoV-2 infection in vivo. Communications biology 6 (1) (2023)
Ling Xu, Chao Wang, Wei Xu, Lixiao Xing, Jie Zhou, Jing Pu, Mingming Fu, Lu Lu, Shibo Jiang, Qian Wang
A dePEGylated Lipopeptide-Based Pan-Coronavirus Fusion Inhibitor Exhibits Potent and Broad-Spectrum Anti-HIV-1 Activity without Eliciting Anti-PEG Antibodies. International journal of molecular sciences 24 (11) (2023)
Qiao Wang, Lujia Sun, Shibo Jiang
Potential recombination between SARS-CoV-2 and MERS-CoV: calls for the development of Pan-CoV vaccines. Signal transduction and targeted therapy 8 (1) (2023)
Mengwen Huang, Xingchao Pan, Xinling Wang, Qingfei Ren, Bei Tong, Xianchi Dong, GaoXiang Ge, Lu Lu, Shibo Jiang, Jian-Feng Chen
Lymphocyte integrins mediate entry and dysregulation of T cells by SARS-CoV-2. Signal transduction and targeted therapy 8 (1) (2023)
Boning Li, Chen Hua, Pu Tian, Yiou Sha, Lu Zhang, Qian Wang, Lu Lu, Shibo Jiang, Long Sui
25-hydroxycholesterol inhibits human papillomavirus infection in cervical epithelial cells by perturbing cytoskeletal remodeling. Journal of medical virology 95 (6) (2023)
Shuai Xia, Lijue Wang, Fanke Jiao, Xueying Yu, Wei Xu, Ziqi Huang, Xicheng Li, Qian Wang, Yun Zhu, Qiuhong Man, Shibo Jiang, Lu Lu
SARS-CoV-2 Omicron subvariants exhibit distinct fusogenicity, but similar sensitivity, to pan-CoV fusion inhibitors. Emerging microbes & infections 12 (1) (2023)
Shuai Xia, Lijue Wang, Fanke Jiao, Xueying Yu, Wei Xu, Ziqi Huang, Xicheng Li, Qian Wang, Yun Zhu, Qiuhong Man, Shibo Jiang, Lu Lu
SARS-CoV-2 Omicron subvariants exhibit distinct fusogenicity, but similar sensitivity, to pan-CoV fusion inhibitors. Emerging microbes & infections 12 (1) (2023)
Qiao Wang, Lujia Sun, Shibo Jiang
Potential recombination between SARS-CoV-2 and MERS-CoV: calls for the development of Pan-CoV vaccines. Signal transduction and targeted therapy 8 (1) (2023)
Songyi Xue, Wei Xu, Lei Wang, Xinling Wang, Qianyu Duan, Laurent Calcul, Shaohui Wang, Wenqi Liu, Xingmin Sun, Lu Lu, Shibo Jiang, Jianfeng Cai
An HR2-Mimicking Sulfonyl-γ-AApeptide Is a Potent Pan-coronavirus Fusion Inhibitor with Strong Blood-Brain Barrier Permeability, Long Half-Life, and Promising Oral Bioavailability. ACS central science 9 (5) (2023)
Shibo Li, Jianbo Wu, Weiyu Jiang, Haiyan He, Yunjiao Zhou, Wei Wu, Yidan Gao, Minxiang Xie, Anqi Xia, Jiaying He, Qianqian Zhang, Yuru Han, Nan Wang, Guangqi Zhu, Qiujing Wang, Zheen Zhang, Christian T Mayer, Kang Wang, Xiangxi Wang, Junqing Wang, Zhenguo Chen, Shibo Jiang, Lei Sun, Rong Xia, Qiao Wang
Characterization of cross-reactive monoclonal antibodies against SARS-CoV-1 and SARS-CoV-2: Implication for rational design and development of pan-sarbecovirus vaccines and neutralizing antibodies. Journal of medical virology 95 (2) (2023)
Xinling Wang, Lu Lu, Shibo Jiang
SARS-CoV-2 Omicron subvariant BA.2.86: limited potential for global spread. Signal transduction and targeted therapy 8 (1) (2023)
Pan Huang, Lujia Sun, Jinhao Li, Qingyi Wu, Nima Rezaei, Shibo Jiang, Chungen Pan
Potential cross-species transmission of highly pathogenic avian influenza H5 subtype (HPAI H5) viruses to humans calls for the development of H5-specific and universal influenza vaccines. Cell discovery 9 (1) (2023)
Shuai Xia, Lijue Wang, Fanke Jiao, Xueying Yu, Wei Xu, Ziqi Huang, Xicheng Li, Qian Wang, Yun Zhu, Qiuhong Man, Shibo Jiang, Lu Lu
SARS-CoV-2 Omicron subvariants exhibit distinct fusogenicity, but similar sensitivity, to pan-CoV fusion inhibitors. Emerging microbes & infections 12 (1) (2023)
Tianyu Lu, Qiuhong Man, Shuai Xia, Xiaohang Liu, Yan Yan, Xueying Yu, Yan Fu, Wanli Liu, Lu Lu, Shibo Jiang, Lize Xiong
Multiple-cohort study of the elderly to determine the immunological characteristics and pathogenic mechanisms of severe community-acquired pneumonia caused by the low-virulence virus SARS-CoV-2 Omicron variant. Cell discovery 9 (1) (2023)
Fanke Jiao, Alexander M Andrianov, Lijue Wang, Konstantin V Furs, Anna V Gonchar, Qian Wang, Wei Xu, Lu Lu, Shuai Xia, Alexander V Tuzikov, Shibo Jiang
Repurposing Navitoclax to block SARS-CoV-2 fusion and entry by targeting heptapeptide repeat sequence 1 in S2 protein. Journal of medical virology 95 (10) (2023)
Naru Zhang, Qianting Ji, Zezhong Liu, Kaiming Tang, Yubin Xie, Kangchen Li, Jie Zhou, Sisi Li, Haotian Shang, Zecan Shi, Tianyu Zheng, Jiawei Yao, Lu Lu, Shuo-Feng Yuan, Shibo Jiang
Effect of Different Adjuvants on Immune Responses Elicited by Protein-Based Subunit Vaccines against SARS-CoV-2 and Its Delta Variant. Viruses 14 (3) (2022)
Jie Zhou, Zezhong Liu, Guangxu Zhang, Wei Xu, Lixiao Xing, Lu Lu, Qian Wang, Shibo Jiang
Development of variant-proof severe acute respiratory syndrome coronavirus 2, pan-sarbecovirus, and pan-β-coronavirus vaccines. Journal of medical virology (2022)
Shibo Li, Jianbo Wu, Weiyu Jiang, Haiyan He, Yunjiao Zhou, Wei Wu, Yidan Gao, Minxiang Xie, Anqi Xia, Jiaying He, Qianqian Zhang, Yuru Han, Nan Wang, Guangqi Zhu, Qiujing Wang, Zheen Zhang, Christian T Mayer, Kang Wang, Xiangxi Wang, Junqing Wang, Zhenguo Chen, Shibo Jiang, Lei Sun, Rong Xia, Qiao Wang
Characterization of cross-reactive monoclonal antibodies against SARS-CoV-1 and SARS-CoV-2: implication for rational design and development of pan-sarbecovirus vaccines and neutralizing antibodies. Journal of medical virology (2022)
Xinling Wang, Zezhong Liu, Lu Lu, Shibo Jiang
The putative mechanism of lymphopenia in COVID-19 patients. Journal of molecular cell biology 14 (5) (2022)
Zezhong Liu, Jasper Fuk-Woo Chan, Jie Zhou, Meiyu Wang, Qian Wang, Guangxu Zhang, Wei Xu, Kenn Ka-Heng Chik, Yilong Zhang, You-Chun Wang, Kwok-Yung Yuen, Lu Lu, Shibo Jiang
A pan-sarbecovirus vaccine induces highly potent and durable neutralizing antibody responses in non-human primates against SARS-CoV-2 Omicron variant. Cell research 32 (5) (2022)
Yuhong Fu, Peiyu Li, Wei Xu, Zezhong Liu, Cong Wang, Qian Wang, Jiayi Tang, Weihua Li, Lu Lu, Shibo Jiang
Chemically Modified Bovine β-Lactoglobulin as a Broad-Spectrum Influenza Virus Entry Inhibitor with the Potential to Combat Influenza Outbreaks. Viruses 14 (9) (2022)
Naru Zhang, Kangchen Li, Zezhong Liu, Kutty Selva Nandakumar, Shibo Jiang
A Perspective on the Roles of Adjuvants in Developing Highly Potent COVID-19 Vaccines. Viruses 14 (2) (2022)
Shibo Li, Jianbo Wu, Weiyu Jiang, Haiyan He, Yunjiao Zhou, Wei Wu, Yidan Gao, Minxiang Xie, Anqi Xia, Jiaying He, Qianqian Zhang, Yuru Han, Nan Wang, Guangqi Zhu, Qiujing Wang, Zheen Zhang, Christian T Mayer, Kang Wang, Xiangxi Wang, Junqing Wang, Zhenguo Chen, Shibo Jiang, Lei Sun, Rong Xia, Qiao Wang
Characterization of cross-reactive monoclonal antibodies against SARS-CoV-1 and SARS-CoV-2: implication for rational design and development of pan-sarbecovirus vaccines and neutralizing antibodies. Journal of medical virology (2022)
Shuai Xia, Lijue Wang, Yun Zhu, Lu Lu, Shibo Jiang
Origin, virological features, immune evasion and intervention of SARS-CoV-2 Omicron sublineages. Signal transduction and targeted therapy 7 (1) (2022)
Simeng Zhao, Fengjiang Liu, Shizhen Qiu, Qiaoshuai Lan, Yiran Wu, Wei Xu, Junzi Ke, Jie Yang, Xiaoyan Liu, Kun Wang, Hangtian Guo, Shuai Xia, Fangfang Zhang, Jiabei Wang, Xiaowen Hu, Lu Lu, Shibo Jiang, Suwen Zhao, Lianxin Liu, Youhua Xie, Xiu-Na Yang, Haopeng Wang, Guisheng Zhong
A core epitope targeting antibody of SARS-CoV-2. Protein & cell 14 (1) (2022)
Simeng Zhao, Fengjiang Liu, Shizhen Qiu, Qiaoshuai Lan, Yiran Wu, Wei Xu, Junzi Ke, Jie Yang, Xiaoyan Liu, Kun Wang, Hangtian Guo, Shuai Xia, Fangfang Zhang, Jiabei Wang, Xiaowen Hu, Lu Lu, Shibo Jiang, Suwen Zhao, Lianxin Liu, Youhua Xie, Xiu-Na Yang, Haopeng Wang, Guisheng Zhong
A core epitope targeting antibody of SARS-CoV-2. Protein & cell 14 (1) (2022)
Shuai Xia, Jasper Fuk-Woo Chan, Lijue Wang, Fanke Jiao, Kenn Ka-Heng Chik, Hin Chu, Qiaoshuai Lan, Wei Xu, Qian Wang, Chao Wang, Kwok-Yung Yuen, Lu Lu, Shibo Jiang
Peptide-based pan-CoV fusion inhibitors maintain high potency against SARS-CoV-2 Omicron variant. Cell research 32 (4) (2022)
Xiaojuan Liu, Cun Li, Zhixin Wan, Man Chun Chiu, Jingjing Huang, Yifei Yu, Lin Zhu, Jian-Piao Cai, Lei Rong, You-Qiang Song, Hin Chu, Zongwei Cai, Shibo Jiang, Kwok-Yung Yuen, Jie Zhou
Analogous comparison unravels heightened antiviral defense and boosted viral infection upon immunosuppression in bat organoids. Signal transduction and targeted therapy 7 (1) (2022)
Yingdan Wang, Meiqin Liu, Yaping Shen, Yunping Ma, Xiang Li, Yuanyuan Zhang, Mei Liu, Xing-Lou Yang, Jun Chen, Renhong Yan, Die Luan, Yanqun Wang, Ying Chen, Qimin Wang, Haofeng Lin, Yaning Li, Kaiyue Wu, Tongyu Zhu, Jin-Cun Zhao, Hongzhou Lu, Yumei Wen, Shibo Jiang, Fan Wu, Qiang Zhou, Zheng-Li Shi, Jinghe Huang
Novel sarbecovirus bispecific neutralizing antibodies with exceptional breadth and potency against currently circulating SARS-CoV-2 variants and sarbecoviruses. Cell discovery 8 (1) (2022)
Simeng Zhao, Fengjiang Liu, Shizhen Qiu, Qiaoshuai Lan, Yiran Wu, Wei Xu, Junzi Ke, Jie Yang, Xiaoyan Liu, Kun Wang, Hangtian Guo, Shuai Xia, Fangfang Zhang, Jiabei Wang, Xiaowen Hu, Lu Lu, Shibo Jiang, Suwen Zhao, Lianxin Liu, Youhua Xie, Xiu-Na Yang, Haopeng Wang, Guisheng Zhong
A core epitope targeting antibody of SARS-CoV-2. Protein & cell 14 (1) (2022)
Zezhong Liu, Lu Lu, Shibo Jiang
Up or down: where comes Omicron? Cell research 32 (7) (2022)
Xiaoyu Zhao, Cun Li, Man-Chun Chiu, Rui Qiao, Shibo Jiang, Pengfei Wang, Jie Zhou
Rock1 is a novel host dependency factor of human enterovirus A71: Implication as a drug target. Journal of medical virology 94 (11) (2022)
Yanjia Chen, Xiaoyu Zhao, Hao Zhou, Huanzhang Zhu, Shibo Jiang, Pengfei Wang
Broadly neutralizing antibodies to SARS-CoV-2 and other human coronaviruses. Nature reviews. Immunology (2022)
Xun Wang, Xiaoyu Zhao, Yuchen Cui, Rui Qiao, Minghui Li, Yanjia Chen, Lulu Yang, Shibo Jiang, Pengfei Wang
Neutralization of distinct Omicron sublineages by longitudinal vaccination sera. Journal of medical virology 94 (11) (2022)
Xiaojuan Liu, Cun Li, Zhixin Wan, Man Chun Chiu, Jingjing Huang, Yifei Yu, Lin Zhu, Jian-Piao Cai, Lei Rong, You-Qiang Song, Hin Chu, Zongwei Cai, Shibo Jiang, Kwok-Yung Yuen, Jie Zhou
Analogous comparison unravels heightened antiviral defense and boosted viral infection upon immunosuppression in bat organoids. Signal transduction and targeted therapy 7 (1) (2022)
Songyi Xue, Xinling Wang, Lei Wang, Wei Xu, Shuai Xia, Lujia Sun, Shaohui Wang, Ning Shen, Ziqi Yang, Bo Huang, Sihao Li, Chuanhai Cao, Laurent Calcul, Xingmin Sun, Lu Lu, Jianfeng Cai, Shibo Jiang
A novel cyclic γ-AApeptide-based long-acting pan-coronavirus fusion inhibitor with potential oral bioavailability by targeting two sites in spike protein. Cell discovery 8 (1) (2022)
Qianyu Duan, Shuai Xia, Fanke Jiao, Qian Wang, Rui Wang, Lu Lu, Shibo Jiang, Wei Xu
A Modified Fibronectin Type III Domain-Conjugated, Long-Acting Pan-Coronavirus Fusion Inhibitor with Extended Half-Life. Viruses 14 (4) (2022)
Junying Liu, Shouli Yuan, Yao Yao, Jinfan Wang, Gaia Scalabrino, Shibo Jiang, Helen Sheridan
Network Pharmacology and Molecular Docking Elucidate the Underlying Pharmacological Mechanisms of the Herb Houttuynia cordata in Treating Pneumonia Caused by SARS-CoV-2. Viruses 14 (7) (2022)
Qiaoshuai Lan, Lijue Wang, Fanke Jiao, Lu Lu, Shuai Xia, Shibo Jiang
Pan-coronavirus fusion inhibitors to combat COVID-19 and other emerging coronavirus infectious diseases. Journal of medical virology (2022)
Zezhong Liu, Jie Zhou, Wei Xu, Wei Deng, Yanqun Wang, Meiyu Wang, Qian Wang, Ming Hsieh, Jingming Dong, Xinling Wang, Wei Jin Huang, Lixiao Xing, Miaoling He, Chunlin Tao, You-Hua Xie, Yilong Zhang, You-Chun Wang, Jin-Cun Zhao, Zhenghong Yuan, Chuan Qin, Shibo Jiang, Lu Lu
A novel STING agonist-adjuvanted pan-sarbecovirus vaccine elicits potent and durable neutralizing antibody and T cell responses in mice, rabbits and NHPs. Cell research 32 (3) (2022)
Jing Pu, Xiao-Yang He, Wei Xu, Cong Wang, Qiaoshuai Lan, Chen Hua, Kai Wang, Lu Lu, Shibo Jiang
The Analogs of Furanyl Methylidene Rhodanine Exhibit Broad-Spectrum Inhibitory and Inactivating Activities against Enveloped Viruses, including SARS-CoV-2 and Its Variants. Viruses 14 (3) (2022)
Shibo Li, Jianbo Wu, Weiyu Jiang, Haiyan He, Yunjiao Zhou, Wei Wu, Yidan Gao, Minxiang Xie, Anqi Xia, Jiaying He, Qianqian Zhang, Yuru Han, Nan Wang, Guangqi Zhu, Qiujing Wang, Zheen Zhang, Christian T Mayer, Kang Wang, Xiangxi Wang, Junqing Wang, Zhenguo Chen, Shibo Jiang, Lei Sun, Rong Xia, Qiao Wang
Characterization of cross-reactive monoclonal antibodies against SARS-CoV-1 and SARS-CoV-2: implication for rational design and development of pan-sarbecovirus vaccines and neutralizing antibodies. Journal of medical virology (2022)
Wei Pang, Ying Lu, Yan-Bo Zhao, Fan Shen, Chang-Fa Fan, Qian Wang, Wen-Qiang He, Xiao-Yan He, Ze-Kai Li, Tao-Tao Chen, Cui-Xian Yang, You-Zhi Li, Si-Xuan Xiao, Zu-Jiang Zhao, Xu-Sheng Huang, Rong-Hua Luo, Liu-Meng Yang, Mi Zhang, Xing-Qi Dong, Ming-Hua Li, Xiao-Li Feng, Qing-Cui Zhou, Wang Qu, Shibo Jiang, Songying Ouyang, Yong-Tang Zheng
A variant-proof SARS-CoV-2 vaccine targeting HR1 domain in S2 subunit of spike protein. Cell research 32 (12) (2022)
Lixiao Xing, Xinfeng Xu, Wei Xu, Zezhong Liu, Xin Shen, Jie Zhou, Ling Xu, Jing Pu, Chan Yang, Yuan Huang, Lu Lu, Shibo Jiang, Shu-Wen Liu
A Five-Helix-Based SARS-CoV-2 Fusion Inhibitor Targeting Heptad Repeat 2 Domain against SARS-CoV-2 and Its Variants of Concern. Viruses 14 (3) (2022)
Qiaoshuai Lan, Jasper Fuk-Woo Chan, Wei Xu, Lijue Wang, Fanke Jiao, Guangxu Zhang, Jing Pu, Jie Zhou, Shuai Xia, Lu Lu, Kwok-Yung Yuen, Shibo Jiang, Qian Wang
A Palmitic Acid-Conjugated, Peptide-Based pan-CoV Fusion Inhibitor Potently Inhibits Infection of SARS-CoV-2 Omicron and Other Variants of Concern. Viruses 14 (3) (2022)
Wei Xu, Zhe Cong, Qianyu Duan, Qian Wang, Shan Su, Rui Wang, Lu Lu, Jing Xue, Shibo Jiang
A Protein-Based, Long-Acting HIV-1 Fusion Inhibitor with an Improved Pharmacokinetic Profile. Pharmaceuticals (Basel, Switzerland) 15 (4) (2022)
Man-Chun Chiu, Cun Li, Xiaojuan Liu, Yifei Yu, Jingjing Huang, Zhixin Wan, Ding Xiao, Hin Chu, Jian-Piao Cai, Biao Zhou, Ko-Yung Sit, Wing-Kuk Au, Kenneth Kak-Yuen Wong, Gang Li, Jasper Fuk-Woo Chan, Kelvin Kai Wang To, Zhiwei Chen, Shibo Jiang, Hans Clevers, Kwok-Yung Yuen, Jie Zhou
A bipotential organoid model of respiratory epithelium recapitulates high infectivity of SARS-CoV-2 Omicron variant. Cell discovery 8 (1) (2022)
Xiaojuan Liu, Cun Li, Zhixin Wan, Man Chun Chiu, Jingjing Huang, Yifei Yu, Lin Zhu, Jian-Piao Cai, Lei Rong, You-Qiang Song, Hin Chu, Zongwei Cai, Shibo Jiang, Kwok-Yung Yuen, Jie Zhou
Analogous comparison unravels heightened antiviral defense and boosted viral infection upon immunosuppression in bat organoids. Signal transduction and targeted therapy 7 (1) (2022)
Xiaojuan Liu, Cun Li, Zhixin Wan, Man Chun Chiu, Jingjing Huang, Yifei Yu, Lin Zhu, Jian-Piao Cai, Lei Rong, You-Qiang Song, Hin Chu, Zongwei Cai, Shibo Jiang, Kwok-Yung Yuen, Jie Zhou
Analogous comparison unravels heightened antiviral defense and boosted viral infection upon immunosuppression in bat organoids. Signal transduction and targeted therapy 7 (1) (2022)
Shuwen Liu, Weihua Li, Shibo Jiang
Disease of influenza virus and SARS-CoV-2 coinfection: Flurona or Flucovid? Journal of medical virology 94 (9) (2022)
Zhongtian Qi, Jianbo Wu, Shibo Jiang
Renaming the SARS-CoV-2 Omicron sublineages as SARS-CoV-3 is contrary to nomenclature standards based on evolutionary and serological evidence. Clinical and translational medicine 12 (6) (2022)
Hanjun Zhao, Kelvin Kai Wang To, Hoiyan Lam, Xinxin Zhou, Jasper Fuk-Woo Chan, Zheng Peng, Andrew Chak-Yiu Lee, Jianpiao Cai, Wan-Mui Chan, Jonathan Daniel Ip, Chris Chung-Sing Chan, Man Lung Yeung, Anna Jinxia Zhang, Allen Wing Ho Chu, Shibo Jiang, Kwok-Yung Yuen
Cross-linking peptide and repurposed drugs inhibit both entry pathways of SARS-CoV-2. Nature communications 12 (1) (2021)
Qiaoshuai Lan, Chao Wang, Jie Zhou, Lijue Wang, Fanke Jiao, Yanbo Zhang, Yanxing Cai, Lu Lu, Shuai Xia, Shibo Jiang
25-Hydroxycholesterol-Conjugated EK1 Peptide with Potent and Broad-Spectrum Inhibitory Activity against SARS-CoV-2, Its Variants of Concern, and Other Human Coronaviruses. International journal of molecular sciences 22 (21) (2021)
Xinling Wang, Miao Cao, Yanling Wu, Wei Xu, Qian Wang, Tianlei Ying, Lu Lu, Shibo Jiang
Synergistic Effect by Combining a gp120-Binding Protein and a gp41-Binding Antibody to Inactivate HIV-1 Virions and Inhibit HIV-1 Infection. Molecules (Basel, Switzerland) 26 (7) (2021)
Zezhong Liu, Wei Xu, Zhenguo Chen, Wangjun Fu, Wuqiang Zhan, Yidan Gao, Jie Zhou, Yunjiao Zhou, Jianbo Wu, Qian Wang, Xiang Zhang, Aihua Hao, Wei Wu, Qianqian Zhang, Yaming Li, Kaiyue Fan, Ruihong Chen, Qiaochu Jiang, Christian Thomas Mayer, Till Schoofs, Youhua Xie, Shibo Jiang, Yumei Wen, Zhenghong Yuan, Kang Wang, Lu Lu, Lei Sun, Qiao Wang
An ultrapotent pan-β-coronavirus lineage B (β-CoV-B) neutralizing antibody locks the receptor-binding domain in closed conformation by targeting its conserved epitope. Protein & cell (2021)
Shuai Xia, Zuoling Wen, Lijue Wang, Qiaoshuai Lan, Fanke Jiao, Linhua Tai, Qian Wang, Fei Sun, Shibo Jiang, Lu Lu, Yun Zhu
Structure-based evidence for the enhanced transmissibility of the dominant SARS-CoV-2 B.1.1.7 variant (Alpha). Cell discovery 7 (1) (2021)
Shan Su, Qian Wang, Shibo Jiang
Facing the challenge of viral mutations in the age of pandemic: Developing highly potent, broad-spectrum, and safe COVID-19 vaccines and therapeutics. Clinical and translational medicine 11 (1) (2021)
Qian Wang, Shan Su, Jing Xue, Fei Yu, Jing Pu, Wenwen Bi, Shuai Xia, Yu Meng, Cong Wang, Wenqian Yang, Wei Xu, Yun Zhu, Qinwen Zheng, Chuan Qin, Shibo Jiang, Lu Lu
An amphipathic peptide targeting the gp41 cytoplasmic tail kills HIV-1 virions and infected cells. Science translational medicine 12 (546) (2021)
Shuai Wang, Zongyang Qiu, Yingnan Hou, Xiya Deng, Wei Xu, Tingting Zheng, Peihan Wu, Shaofang Xie, Weixiang Bian, Chong Zhang, Zewei Sun, Kunpeng Liu, Chao Shan, Aifu Lin, Shibo Jiang, Youhua Xie, Qiang Zhou, Lu Lu, Jing Huang, Xu Li
AXL is a candidate receptor for SARS-CoV-2 that promotes infection of pulmonary and bronchial epithelial cells. Cell research 31 (2) (2021)
Fei Li, Ming Han, Pengfei Dai, Wei Xu, Juan He, Xiaoting Tao, Yang Wu, Xinyuan Tong, Xinyi Xia, Wangxin Guo, Yunjiao Zhou, Yunguang Li, Yiqin Zhu, Xiaoyu Zhang, Zhuang Liu, Rebiguli Aji, Xia Cai, Yutang Li, Di Qu, Juliet Chen, Shibo Jiang, Qiao Wang, Hongbin Ji, You-Hua Xie, Yihua Sun, Lu Lu, Wangxin Guo
Distinct mechanisms for TMPRSS2 expression explain organ-specific inhibition of SARS-CoV-2 infection by enzalutamide. Nature communications 12 (1) (2021)
Cheng Li, Xiaolong Tian, Xiaodong Jia, Jinkai Wan, Lu Lu, Shibo Jiang, Fei Lan, Yinying Lu, Yanling Wu, Tianlei Ying
The impact of receptor-binding domain natural mutations on antibody recognition of SARS-CoV-2. Signal transduction and targeted therapy 6 (1) (2021)

Shibo Jiang.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Shibo Jiang